lncRNA CASC11 regulates the progress of delayed fracture healing via sponging miR-150-3p

  • 0Orthopedics, Affiliated Hospital of Hebei University, Baoding, 071000, China.

|

|

Summary

This summary is machine-generated.

Long non-coding RNA CASC11 (lncRNA CASC11) exacerbates delayed tibial fracture healing by sponging miR-150-3p. This interaction suppresses bone regeneration, making lncRNA CASC11 a potential therapeutic target for fracture treatment.

Area Of Science

  • Molecular Biology
  • Biochemistry
  • Regenerative Medicine

Background

  • Long non-coding RNAs (lncRNAs) are crucial regulators in bone regeneration, mediating processes through interactions with microRNAs (miRNAs).
  • Dysregulation of lncRNA-miRNA networks is implicated in impaired bone healing.
  • Understanding specific lncRNA roles is vital for developing therapeutic strategies.

Purpose Of The Study

  • To investigate the role of lncRNA CASC11 in delayed tibial fracture healing.
  • To explore the underlying molecular mechanisms involving miR-150-3p.
  • To assess the diagnostic potential of CASC11 in fracture patients.

Main Methods

  • Serum CASC11 and miR-150-3p expression analysis in fracture patients.
  • Confirmation of CASC11-miR-150-3p binding interactions.
  • In vitro studies using MC3T3-E1 cells with CASC11/miR-150-3p manipulation to assess osteogenic gene expression, cell proliferation, and apoptosis.

Main Results

  • Elevated serum CASC11 and decreased miR-150-3p levels correlate with delayed fracture healing.
  • CASC11 inhibits osteogenic marker gene expression, reduces cell proliferation, and increases apoptosis in bone cells.
  • miR-150-3p overexpression counteracts CASC11's negative effects on osteogenesis and apoptosis.

Conclusions

  • lncRNA CASC11 sponges miR-150-3p, contributing to delayed tibial fracture healing.
  • CASC11 represents a promising therapeutic target for enhancing fracture repair.